在肺腺癌中,MAZ促进瘤扩散和免疫逃避
Yan Chen1, Xinsheng Zhu1, Jue Wang1
1Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.
Oncogene
|October 18, 2024
概括
与MYC相关的指蛋白 (MAZ) 通过调节KRAS信号来促进肺腺癌 (LUAD) 的生长和免疫逃逸. 向MAZ可能会改善LUAD治疗,并提高免疫检查点阻塞疗法的有效性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肺腺癌 (LUAD) 是癌症死亡的主要原因,需要新的治疗策略.
- 识别新的分子标对于改善LUAD治疗结果至关重要.
研究的目的:
- 研究MYC相关的指蛋白 (MAZ) 在LUAD进展和免疫逃避中的作用.
- 探索MAZ作为LUAD的潜在治疗标及其对免疫检查点阻塞 (ICB) 疗法的影响.
主要方法:
- 在LUAD组织中MAZ表达的分析和与患者存活率的相关性.
- 试验室研究涉及MAZ沉默,以评估对瘤增殖,化学因表达和加勒-9 (Gal-9) 水平的影响.
- 调查MAZ,KRAS,AKT-NF-κB信号传递和免疫抑制之间的机制联系.
- 在体内动物模型和生物信息分析评估MAZ抑制与ICB疗法结合.
主要成果:
- 在LUAD组织中,MAZ被上调,更高的表达与较差的患者存活率相关.
- 抑制MAZ降低了LUAD细胞的增殖,并抑制了前瘤源的化学基因和Gal-9,这是免疫抑制的关键媒介.
- 发现MAZ通过转录调节KRAS,激活AKT-NF-κB通路,从而驱动瘤进展和免疫逃避.
- 在临床前的LUAD模型中,MAZ抑制增强了ICB治疗的疗效.
结论:
- MAZ是通过KRAS/AKT/NF-κB信号轴的LUAD细胞增殖和免疫逃逸的关键调节者.
- MAZ 是一个 LUAD 治疗的有前途的分子标.
- 向MAZ有可能提高LUAD患者免疫检查点阻塞疗法的有效性.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K